|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Products and services revenue | |||||
| License and royalty revenue | |||||
| Total revenue | |||||
| Cost of products and services revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Accrued contingent liabilities | |||||
| Gain on settlement | |||||
| In-process research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Total other income | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Comprehensive loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Weighted-average shares used to compute net loss per share, basic (in shares) | |||||
| Weighted-average shares used to compute net loss per share, diluted (in shares) | |||||
Loading...